Literature DB >> 26210244

Percutaneous Irreversible Electroporation for Recurrent Thyroid Cancer--A Case Report.

Martijn R Meijerink1, Hester J Scheffer2, Remco de Bree3, Robert-Jan Sedee3.   

Abstract

A 74-year-old man presented with a small locoregional, histopathologically proven, fluorodeoxyglucose positron emission tomography/computed tomography-avid recurrence of follicular thyroid carcinoma in the left subglottic space after extensive surgical resection, adjuvant radioactive iodine therapy, and external beam radiation therapy. Because all established focal therapies were contraindicated, percutaneous irreversible electroporation was performed without complications. Follow-up imaging at 7 months showed a small ablation scar without signs for residual vital tumor tissue. Irreversible electroporation may be a viable treatment option for selected cases of recurring head and neck tumors that are unsuitable for other local treatments.
Copyright © 2015 SIR. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26210244     DOI: 10.1016/j.jvir.2015.05.004

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  1 in total

1.  Antitumor Efficacy of Liposome-Encapsulated NVP-BEZ235 Combined with Irreversible Electroporation for Head and Neck Cancer.

Authors:  Li Tian; Lucas Wang; Yang Qiao; Linfeng Lu; Patrick Lee; Ashley Chang; Saisree Ravi; Thomas A Rogers; Marites P Melancon
Journal:  Molecules       Date:  2019-10-01       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.